These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23803727)

  • 1. Keeping each other in check: a reciprocal relationship between cytokines and miRNA.
    Andersen MH
    Cell Cycle; 2013 Jul; 12(14):2171. PubMed ID: 23803727
    [No Abstract]   [Full Text] [Related]  

  • 2. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155.
    Litvinov IV; Pehr K; Sasseville D
    Cell Cycle; 2013 Jul; 12(14):2172-3. PubMed ID: 23803726
    [No Abstract]   [Full Text] [Related]  

  • 3. miR-155 meets the JAK/STAT pathway.
    Persson JL
    Cell Cycle; 2013 Jul; 12(14):2170. PubMed ID: 23803728
    [No Abstract]   [Full Text] [Related]  

  • 4. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
    Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
    Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
    Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
    Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
    Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
    Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
    Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
    Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.
    Abraham RM; Zhang Q; Odum N; Wasik MA
    Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and
    Hedl M; Sun R; Huang C; Abraham C
    J Immunol; 2019 Dec; 203(12):3325-3338. PubMed ID: 31732533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells.
    Qin JZ; Kamarashev J; Zhang CL; Dummer R; Burg G; Döbbeling U
    J Invest Dermatol; 2001 Sep; 117(3):583-9. PubMed ID: 11564163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.
    Lauenborg B; Christensen L; Ralfkiaer U; Kopp KL; Jønson L; Dabelsteen S; Bonefeld CM; Geisler C; Gjerdrum LM; Zhang Q; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Oncotarget; 2015 Jun; 6(17):15235-49. PubMed ID: 25915535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma].
    Yue L; Cheng J; Zhang Pf; Lin G; Yi Z; Zhang R
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Oct; 20(20):931-3, 936. PubMed ID: 17225522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.
    Selliah N; Zhang M; DeSimone D; Kim H; Brunner M; Ittenbach RF; Rui H; Cron RQ; Finkel TH
    Virology; 2006 Jan; 344(2):283-91. PubMed ID: 16289657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permission to proceed: Jak3 and STAT5 signaling molecules give the green light for T helper 1 cell differentiation.
    Murphy KM
    Immunity; 2008 Jun; 28(6):725-7. PubMed ID: 18549792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein expression in cutaneous T cell lymphoma.
    de Misa RF; Azaña JM; Harto A; Bellas C
    J Dermatol Sci; 1993 Jun; 5(3):212-3. PubMed ID: 8305055
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2.
    Ren Z; Aerts JL; Vandenplas H; Wang JA; Gorbenko O; Chen JP; Giron P; Heirman C; Goyvaerts C; Zacksenhaus E; Minden MD; Stambolic V; Breckpot K; De Grève J
    Cell Death Dis; 2016 Dec; 7(12):e2560. PubMed ID: 28005077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5.
    Xiao M; Zhang L; Zhou Y; Rajoria P; Wang C
    Biochem Biophys Res Commun; 2016 Jan; 469(3):716-22. PubMed ID: 26707639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.